{
    "title": "Case report: a transcatheter aortic valve replacement failure secondary to COVID-19 infection.",
    "doc_id": "36845835",
    "writer": "Tacon PR",
    "year": "2023",
    "summary": "Case reports have been published of prosthetic valve thrombosis secondary to COVID-19 infection. This is the first case report of COVID-19 associated valve thrombosis in a patient with transcatheter aortic valve replacement (TAVR). ...She underwent valve-in-valve TA â€¦",
    "abstract": "Background:\n        \n      \n      Valve thrombosis is a well-documented cause of bioprosthetic valve failure. Case reports have been published of prosthetic valve thrombosis secondary to COVID-19 infection. This is the first case report of COVID-19 associated valve thrombosis in a patient with transcatheter aortic valve replacement (TAVR).\n    \n\n\n          Case summary:\n        \n      \n      A 90-year-old female with atrial fibrillation on therapeutic apixaban and status-post TAVR presented with COVID-19 infection and was found to have severe bioprosthetic valvular regurgitation with features suggestive of valve thrombosis. She underwent valve-in-valve TAVR with resolution of valvular dysfunction.\n    \n\n\n          Discussion:\n        \n      \n      This case report contributes to a growing body of evidence describing the occurrence of thrombotic complications in patients with valve replacement and COVID-19 infection. Increased vigilance and continued investigation are warranted to better characterize thrombotic risk and to inform optimal antithrombotic strategies during COVID-19 infection.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/36845835/",
    "clean_text": "case report a transcatheter aortic valve replacement failure secondary to covid infection case reports have been published of prosthetic valve thrombosis secondary to covid infection this is the first case report of covid associated valve thrombosis in a patient with transcatheter aortic valve replacement tavr she underwent valve in valve ta background valve thrombosis is a well documented cause of bioprosthetic valve failure case reports have been published of prosthetic valve thrombosis secondary to covid infection this is the first case report of covid associated valve thrombosis in a patient with transcatheter aortic valve replacement tavr case summary a year old female with atrial fibrillation on therapeutic apixaban and status post tavr presented with covid infection and was found to have severe bioprosthetic valvular regurgitation with features suggestive of valve thrombosis she underwent valve in valve tavr with resolution of valvular dysfunction discussion this case report contributes to a growing body of evidence describing the occurrence of thrombotic complications in patients with valve replacement and covid infection increased vigilance and continued investigation are warranted to better characterize thrombotic risk and to inform optimal antithrombotic strategies during covid infection"
}